D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
HF Sinclair
DINO
$15.9B
| $32.4M | 0.04% |
602,441
-970,254
| -62% | -$48M |
|
527
IPG Photonics
IPGP
$3.89B
| $32.4M | 0.04% |
384,038
-15,941
| -4% | -$1.51M |
|
528
Philip Morris
PM
$301B
| $32.3M | 0.04% |
389,551
+263,230
| +208% | +$25.1M |
|
529
Rambus
RMBS
$10.4B
| $32.3M | 0.04% |
1,271,753
-26,253
| -2% | -$656K |
|
530
PUT
Zebra Technologies
ZBRA
$12.4B
| $32.3M | 0.04% |
123,100
-20,000
| -14% | -$6.19M |
|
531
PUT
ServiceNow
NOW
$102B
| $32.2M | 0.04% |
426,500
-50,000
| -10% | -$4.5M |
|
|
IPG
532
DELISTED
Interpublic Group of Companies
IPG
| $32.2M | 0.04% |
1,257,325
+650,768
| +107% | +$18.5M |
|
533
Moderna
MRNA
$21.5B
| $32.2M | 0.04% |
272,166
+245,352
| +915% | +$37.2M |
|
534
PUT
Ulta Beauty
ULTA
$20.4B
| $32.1M | 0.04% |
80,000
+46,400
| +138% | +$18.7M |
|
535
CALL
Diamondback Energy
FANG
$57.6B
| $32M | 0.04% |
265,400
+101,500
| +62% | +$12.7M |
|
536
PUT
Altria Group
MO
$122B
| $31.9M | 0.04% |
790,700
+216,800
| +38% | +$9.46M |
|
537
Celanese
CE
$5.09B
| $31.9M | 0.04% |
353,063
+117,493
| +50% | +$12.9M |
|
538
Roper Technologies
ROP
$36.3B
| $31.9M | 0.04% |
88,599
+27,918
| +46% | +$11.4M |
|
539
Teva Pharmaceuticals
TEVA
$35.9B
| $31.8M | 0.04% |
3,944,335
+2,631,829
| +201% | +$23.3M |
|
540
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
| $31.8M | 0.04% |
255,200
+136,300
| +115% | +$18M |
|
541
Consolidated Edison
ED
$41.6B
| $31.8M | 0.04% |
370,918
+6,962
| +2% | +$672K |
|
542
Academy Sports + Outdoors
ASO
$2.89B
| $31.5M | 0.04% |
747,132
+173,333
| +30% | +$7.59M |
|
543
Bristol-Myers Squibb
BMY
$127B
| $31.4M | 0.04% |
441,853
-295,626
| -40% | -$21.4M |
|
|
ZEN
544
DELISTED
ZENDESK INC
ZEN
| $31.4M | 0.04% |
412,364
+354,868
| +617% | +$26.9M |
|
545
PUT
Capital One
COF
$124B
| $31.3M | 0.04% |
339,600
+134,600
| +66% | +$14.3M |
|
546
CALL
ASML
ASML
$675B
| $31.2M | 0.04% |
75,200
+58,500
| +350% | +$29.3M |
|
547
CALL
Delta Air Lines
DAL
$55.9B
| $31.2M | 0.04% |
1,112,200
+88,300
| +9% | +$2.8M |
|
548
PUT
Merck
MRK
$324B
| $31.1M | 0.04% |
361,700
+282,900
| +359% | +$25.3M |
|
549
ChargePoint
CHPT
$133M
| $31.1M | 0.04% |
105,475
+98,073
| +1,325% | +$29.8M |
|
|
X
550
CALL
DELISTED
US Steel
X
| $31M | 0.04% |
1,712,600
+821,500
| +92% | +$17.6M |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.